Tag: Nerlynx

May 7, 2020 Off

Canbridge gets marketing approval of Nerlynx in China

By BusinessWire

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its licensing partner CANbridge Pharmaceuticals, Inc. has received marketing approval of NERLYNX® (neratinib) in mainland China from the National Medical Products Administration (NMPA) of China.